Filing Details
- Accession Number:
- 0001179110-14-010033
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-09 18:09:18
- Reporting Period:
- 2014-06-06
- Filing Date:
- 2014-06-09
- Accepted Time:
- 2014-06-09 17:09:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1260990 | Gtx Inc | GTXI | Pharmaceutical Preparations (2834) | 621715807 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1314981 | T James Dalton | 175 Toyota Plaza 7Th Floor Memphis TN 38103 | Vp, Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-06-06 | 72,883 | $1.30 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- An aggregate of 72,883 shares of common stock were sold in multiple trades on June 6, 2014 at prices ranging from $1.30 to $1.315. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, GTx, Inc. or a shareholder of GTx, Inc. full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
